BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28330758)

  • 1. Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review.
    Chen K; Liu J; Cao X
    J Autoimmun; 2017 Sep; 83():1-11. PubMed ID: 28330758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Translational Modification Control of Innate Immunity.
    Liu J; Qian C; Cao X
    Immunity; 2016 Jul; 45(1):15-30. PubMed ID: 27438764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of type I interferon responses.
    Ivashkiv LB; Donlin LT
    Nat Rev Immunol; 2014 Jan; 14(1):36-49. PubMed ID: 24362405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.
    Kosciuczuk EM; Mehrotra S; Saleiro D; Kroczynska B; Majchrzak-Kita B; Lisowski P; Driehaus C; Rogalska A; Turner A; Lienhoop T; Gius D; Fish EN; Vassilopoulos A; Platanias LC
    J Biol Chem; 2019 Jan; 294(3):827-837. PubMed ID: 30487288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cross-Regulation Between Autophagy and Type I Interferon Signaling in Host Defense.
    Jin S
    Adv Exp Med Biol; 2019; 1209():125-144. PubMed ID: 31728868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon target-gene expression and epigenomic signatures in health and disease.
    Barrat FJ; Crow MK; Ivashkiv LB
    Nat Immunol; 2019 Dec; 20(12):1574-1583. PubMed ID: 31745335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational regulation of antiviral innate signaling.
    Zhou Y; He C; Wang L; Ge B
    Eur J Immunol; 2017 Sep; 47(9):1414-1426. PubMed ID: 28744851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A central role for RNA in the induction and biological activities of type 1 interferons.
    Li XL; Ezelle HJ; Hsi TY; Hassel BA
    Wiley Interdiscip Rev RNA; 2011; 2(1):58-78. PubMed ID: 21956969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.
    Zhu X; Wang D; Zhou J; Pan T; Chen J; Yang Y; Lv M; Ye X; Peng G; Fang L; Xiao S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?
    Thompson CD; Matta B; Barnes BJ
    Front Immunol; 2018; 9():2622. PubMed ID: 30515152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway.
    Du Z; Wei L; Murti A; Pfeffer SR; Fan M; Yang CH; Pfeffer LM
    J Cell Biochem; 2007 Dec; 102(5):1087-94. PubMed ID: 17910035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.
    Nan Y; Wu C; Zhang YJ
    Front Immunol; 2017; 8():1758. PubMed ID: 29312301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.